Results 91 to 100 of about 9,833 (206)
International Journal of Dermatology, Volume 65, Issue 2, Page 356-358, February 2026.
Noor Mruwat +3 more
wiley +1 more source
Direct cardiovascular effects of glucagon like peptide-1 [PDF]
, 2013 Current gold standard therapeutic strategies for T2DM target insulin resistance or β cell dysfunction as their core mechanisms of action. However, the use of traditional anti-diabetic drugs, in most cases, does not significantly reduce macrovascular ...
Asfandyar Sheikh
core +1 more source
Ten Years of Vildagliptin [PDF]
European Endocrinology, 2017 After many years of limited therapeutic opportunities, the treatment of type 2 diabetes has become more target and pathophysiologically driven. A typical example is represented by the development of the dipeptidyl peptidase-4 (DPP-4) inhibitors, allowing for more physiological regulation of the endocrine pancreas and leading to a previously unmet risk ...
openaire +2 more sources
Pathology and glia type specific changes of the DPP4 activity in the spinal cord contributes to the development and maintenance of hyperalgesia and shapes opioid signalling in chronic pain states [PDF]
, 2017 Altered pain sensations such as hyperalgesia and allodynia are characteristic features of various chronic pain states, and remain difficult to treat.
Alpár, Alán +14 more
core
Circulating dipeptidyl peptidase-4 activity is associated with diabetic retinopathy in type 1 diabetic patients [PDF]
, 2015 PURPOSE: Diabetic retinopathy (DR) is the most frequent complication among patients with type 1 diabetes mellitus (T1DM). Dipeptidyl peptidase-4 (DPP4) is a protease with elevated activity in patients with T1DM.
Blaslov, Kristina +2 more
core +1 more source
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy [PDF]
, 2007 Background: The long-term longitudinal evidence for a relation between coffee intake and hypertension is relatively scarce. Objective: The objective was to assess whether coffee intake is associated with the incidence of hypertension.
Boshuizen, H.C. +8 more
core +2 more sources
Drug Design, Development and Therapy, 2014 Mustafa Cakirca,1 Cumali Karatoprak,1 Mehmet Zorlu,1 Muharrem Kiskac,1 Mustafa Kanat,2 Mehmet Ali Cikrikcioglu,1 Pinar Soysal,3 Mehmet Hursitoglu,4 Ahmet Adil Camli,1 Reha Erkoc,1 Muhammad Abdul-Ghani5 1Internal Medicine Clinic, Faculty of Medicine ...
Cakirca M +10 more
doaj
Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan [PDF]
, 2014 This study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of ...
Bektur, C. +2 more
core
Bullous pemphigoid induced by the dipeptidyl-peptidase IV inhibitors (gliptins) [PDF]
, 2014 Background Bullous pemphigoid (BP) is the most frequent autoimmune blistering dermatosis. Recently, the development of BP in patients treated with gliptins, also known as DPP-4 inhibitors, alone or in association with metformin has been outlined in case ...
SCHAFFER, C.
core
Vascular Health and Risk Management, 2008 Nasser MikhailEndocrinology Division, Olive View-UCLA Medical Center, David-Geffen School of Medicine, CA, USAAbstract: Sitagliptin and vildagliptin represent a new class of anti-diabetic agents that enhance the action of incretin hormones through ...
Nasser Mikhail
doaj